Skip to content

H2020

IB4SD-TRISTAN

Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

Programme
Horizon 2020
Started
Ends
Duration
96 months
Total cost
EUR 22,724,622
EU contribution
EUR 12,000,000
Participants
28 from 8 countries
Topic
H2020_IMI2-2015-07-01
Grant agreement
116106

Coordinated by European Organisation for Research and Treatment of Cancer Aisbl (BEBelgium).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
European Organisation for Research and Treatment of Cancer AisblBEBelgiumCoordinatorEUR 414,480PIC (1.00)
Abbvie Deutschland GmbH & Co KGDEGermanyParticipantEUR 0PIC (1.00)
Bayer AktiengesellschaftDEGermanyParticipantEUR 0PIC (1.00)
Bayer Pharma AGDEGermanyParticipantEUR 0PIC (1.00)
Bruker Biospin GmbH & Co KGDEGermanyParticipantEUR 0PIC (1.00)
Bruker Biospin Mri GmbHDEGermanyParticipantEUR 0PIC (1.00)
Sanofi-Aventis Deutschland GmbHDEGermanyParticipantEUR 0PIC (1.00)
Novo Nordisk A/SDKDenmarkParticipantEUR 0PIC (1.00)
Centre National de la Recherche Scientifique CnrsFRFranceThird partyNot statedknown name (0.95)
Universite Dijon BourgogneFRFranceParticipantEUR 250,000known name (0.95)
Bioxydyn LimitedGBUnited KingdomParticipantEUR 1,958,392PIC (1.00)
Ge Healthcare LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
Glaxosmithkline Research & Development LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
Manchester University Nhs Foundation TrustGBUnited KingdomThird partyNot statedknown name (0.95)
Sheffield Teaching Hospitals Nhs Foundation TrustGBUnited KingdomThird partyNot statedknown name (0.95)
The Leeds Teaching Hospitals National Health Service TrustGBUnited KingdomThird partyNot statedPIC (1.00)
The University of ManchesterGBUnited KingdomParticipantEUR 1,361,021known name (0.95)
The University of SheffieldGBUnited KingdomParticipantEUR 2,077,037known name (0.95)
University of LeedsGBUnited KingdomParticipantEUR 629,336known name (0.95)
Academisch Ziekenhuis GroningenNLNetherlandsParticipantEUR 1,010,313PIC (1.00)
Stichting Amsterdam UmcNLNetherlandsParticipantEUR 75,000known name (0.95)
Stichting Radboud Universitair Medisch CentrumNLNetherlandsParticipantEUR 1,310,232PIC (1.00)
Stichting Radboud UniversiteitNLNetherlandsParticipantEUR 0known name (0.95)
Antaros Medical ABSESwedenParticipantEUR 566,025PIC (1.00)
Chalmers Tekniska Hogskola ABSESwedenParticipantEUR 563,003PIC (1.00)
Lunds UniversitetSESwedenParticipantEUR 721,015known name (0.95)
Truly Labs ABSESwedenParticipantEUR 1,064,146PIC (1.00)
Merck Sharp & Dohme CorpUSUnited StatesParticipantEUR 0PIC (1.00)

Changes of the consortium

First seen on with 28 participants from 8 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.